Skip to content
10-Q

Quarterly Report

4D Molecular Therapeutics, Inc. FDMT

0001193125-25-273343

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 56.13M sh
Shares Diluted Q3 2025 · Sep 30, 2025 55.93M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.55M sh
Shares Diluted Q3 2025 · Sep 30, 2024 53.38M sh
Capex Q3 2025 · Sep 30, 2025 $606K
Capex Q3 2025 · Sep 30, 2024 $2.84M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$137.63M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$88.72M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $48.56M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $149.34M
Stockholders Equity Q3 2025 · Sep 30, 2025 $368.98M
Stockholders Equity Q3 2025 · Jun 30, 2025 $420.89M
Stockholders Equity Q3 2025 · Mar 31, 2025 $469.72M
Stockholders Equity Q3 2025 · Dec 31, 2024 $510.61M
Stockholders Equity Q3 2025 · Sep 30, 2024 $552.95M
Stockholders Equity Q3 2025 · Jun 30, 2024 $588.34M
Stockholders Equity Q3 2025 · Mar 31, 2024 $600.56M
Stockholders Equity Q3 2025 · Dec 31, 2023 $307.83M
Current Liabilities Q3 2025 · Sep 30, 2025 $37.11M
Current Liabilities Q3 2025 · Dec 31, 2024 $29.15M
Total Liabilities Q3 2025 · Sep 30, 2025 $55M
Total Liabilities Q3 2025 · Dec 31, 2024 $49.78M
Current Assets Q3 2025 · Sep 30, 2025 $312.38M
Current Assets Q3 2025 · Dec 31, 2024 $434.93M
Total Assets Q3 2025 · Sep 30, 2025 $423.98M
Total Assets Q3 2025 · Dec 31, 2024 $560.38M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.01
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.85
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.79
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.08
Eps Basic Q3 2025 · Sep 30, 2025 −$1.01
Eps Basic Q3 2025 · Sep 30, 2025 −$2.85
Eps Basic Q3 2025 · Sep 30, 2024 −$0.79
Eps Basic Q3 2025 · Sep 30, 2024 −$2.08
Sga Expense Q3 2025 · Sep 30, 2025 $11.84M
Sga Expense Q3 2025 · Sep 30, 2025 $36.29M
Sga Expense Q3 2025 · Sep 30, 2024 $12.65M
Sga Expense Q3 2025 · Sep 30, 2024 $33.55M
Net Income Q3 2025 · Sep 30, 2025 −$56.88M
Net Income Q3 2025 · Sep 30, 2025 −$159.51M
Net Income Q3 2025 · Jun 30, 2025 −$54.66M
Net Income Q3 2025 · Mar 31, 2025 −$47.97M
Net Income Q3 2025 · Sep 30, 2024 −$43.84M
Net Income Q3 2025 · Sep 30, 2024 −$111.2M
Net Income Q3 2025 · Jun 30, 2024 −$34.95M
Net Income Q3 2025 · Mar 31, 2024 −$32.4M
Operating Income Q3 2025 · Sep 30, 2025 −$61.19M
Operating Income Q3 2025 · Sep 30, 2025 −$174.26M
Operating Income Q3 2025 · Sep 30, 2024 −$51.13M
Operating Income Q3 2025 · Sep 30, 2024 −$131.72M
Revenue Q3 2025 · Sep 30, 2025 $90K
Revenue Q3 2025 · Sep 30, 2025 $119K
Revenue Q3 2025 · Sep 30, 2024 $3K
Revenue Q3 2025 · Sep 30, 2024 $36K